PRESS RELEASE published on 06/18/2024 at 10:00, 1 year 9 months ago Advancing Kidney Care With Solidified Evidence – SphingoTec Presents PenKid at AKI & CRRT Course in Vicenza SphingoTec introduces kidney function biomarker PenKid at AKI & CRRT Course. PenKid addresses AKI diagnostic gaps with real-time assessment and risk prediction capabilities SphingoTec PenKid Kidney Function Biomarker AKI & CRRT Course Biomarker Integration
BRIEF published on 03/26/2024 at 13:05, 2 years ago SphingoTec annonce des changements majeurs dans sa direction Biomarqueurs Innovations Diagnostiques Changements De Gestion SphingoTec Soin Critique
BRIEF published on 03/26/2024 at 13:05, 2 years ago SphingoTec Announces Major Management Changes Biomarkers Management Changes Diagnostic Innovations SphingoTec Critical Care
PRESS RELEASE published on 03/26/2024 at 13:00, 2 years ago SphingoTec Announces Management Changes SphingoTec announces changes in management team with new appointments. Deborah Bergmann appointed as CEO. Dr. Florian Uhle as CMO and Nicole Witzmann as CFO. Company aims to enhance critical care diagnostics Management Team Biomarkers SphingoTec Deborah Bergmann Critical Care Diagnostics
PRESS RELEASE published on 10/05/2023 at 10:00, 2 years 6 months ago New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
PRESS RELEASE published on 09/06/2023 at 10:00, 2 years 7 months ago International Experts Highlight Demand for Diagnostic Innovations as PenKid's Research and Real-World Data Fuels Quest for Improved RRT Liberation Tools
PRESS RELEASE published on 08/31/2023 at 12:30, 2 years 7 months ago Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
PRESS RELEASE published on 05/09/2023 at 10:00, 2 years 10 months ago SphingoTec's Innovative IVD Product sphingotest® penKid® Receives First IVDR Certificate
PRESS RELEASE published on 04/04/2023 at 10:00, 3 years ago ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury
PRESS RELEASE published on 02/23/2023 at 10:00, 3 years 1 month ago SphingoTec Appoints Dr. Florian Uhle as Medical Director
Published on 04/09/2026 at 09:00, 46 minutes ago Bolt Metals Corp. Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 04/09/2026 at 04:25, 5 hours 21 minutes ago Future Fuels Announces Completion of $2 Million Life Offering
Published on 04/09/2026 at 01:50, 7 hours 56 minutes ago CoTec Provides Update on Warrant Acceleration
Published on 04/08/2026 at 23:00, 10 hours 46 minutes ago NXT Energy Solutions Announces SFD Survey Contract
Published on 04/09/2026 at 09:15, 31 minutes ago Circus Awarded Public Procurement Contract by Lithuanian Armed Forces on NATO Eastern Flank
Published on 04/09/2026 at 09:00, 46 minutes ago Shelly Group SE to Join Germany’s SDAX Small Cap Index
Published on 04/09/2026 at 08:30, 1 hour 16 minutes ago Mutares signs agreements to acquire two supplier businesses from Magna to strengthen Amaneos and HiLo Group
Published on 04/09/2026 at 07:00, 2 hours 46 minutes ago bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/09/2026 at 07:00, 2 hours 46 minutes ago bioMérieux lance sa solution de diagnostic moléculaire BIOFIRE® SPOTFIRE® pour l’industrie pharmaceutique afin de renforcer le dépistage rapide des mycoplasmes
Published on 04/08/2026 at 18:17, 15 hours 29 minutes ago Mise à disposition du Rapport sur la solvabilité et la situation financière 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:16, 15 hours 29 minutes ago Mise à disposition des états financiers 2025 du Groupe des Assurances du Crédit Mutuel
Published on 04/08/2026 at 18:02, 15 hours 44 minutes ago Publication of the 2025 Universal Registration Document
